With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class ...

Backed by more than a dozen prominent investors, the startup is advancing into human testing a drug it believes capable of ...

Financing co-led by Sanofi Ventures and Janus Henderson Investors, with participation from new investors Deep Track Capital, EcoR1 Capital, Logos Capital, Balyasny Asset Management L.P., Woodline Part ...

In a drug discovery career spanning more than two decades, Alex Lugovskoy has seen a lot of antibodies come and go. The vast majority of them work by inhibiting a cellular function. Lugovskoy, now the ...

Diagonal Therapeutics is taking shape, launching with $128 million and backed by the likes of BVF Partners, Atlas Venture and RA Capital to develop a pipeline of antibody agonists. The company will ...

Over the last decade, officials have tried a series of steps to rein in cars on Los Angeles streets. They turned parking spaces into micro-parks, converted street corners into trendy plazas and ...